Metformin, a first-line medication for the treatment of type 2 diabetes (T2D), was reported to improve insulin sensitivity and reduce HbA1c levels in statin-treated patients with or without impaired fasting glucose levels9, 10. The gene discussed is INS; the disease is type 2 diabetes mellitus.